Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500107859Phase 4Not yet recruiting
Phase 4, randomised trial in postoperative pain and postoperative nausea and vomiting (PONV) comparing Tegretol PCIA arm with Morphine PCIA arm (2 arms). Primary endpoint: Incidence of postoperative nausea and vomiting at 24 hours. Planned start Aug 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500107859.